Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Antithrombotic Management of Coronary Artery Disease Complicated with Atrial Fibrillation: Interpretation of 2020 Chinese Expert Consensus |
Yaling Han | General Hospital of Northern Theater Command |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Antithrombotic Management of Atrial Fibrillation Complicated with Coronary Artery Disease: Interpretation of 2019 AHA/ACC/HRS Guidelines |
Meilin Liu | Peking University First Hospital |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Antithrombotic Therapy in Patients with Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: Interpretation of the 2018 Updated North American Perspective |
Xiaozeng Wang | General Hospital of Northern Theater Command |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Interpretation of 2018 EHRA Expert Consensus on Antithrombotic Treatment of Atrial Fibrillation with ACS/PCI |
Jinqing Yuan | Fuwai Hospital Chinese Academy of Medical Sciences |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
Application of Dabigatran in Atrial Fibrillation |
Jun Zhu | Fuwai Hospital, Chinese Academy of Medical Sciences |
11:15-11:30 | 11:15-11:30 |
Dual vs. Triple Antithrombotic Therapy after PCI |
Chunjian Li | Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University) |
11:30-11:45 | 11:30-11:45 |
Antithrombotic Therapy After PCI: From RE-DUAL PCI to Complex Clinical Cases |
Jun Jin | Xinqiao Hospital, Army Medical University |
11:45-12:00 | 11:45-12:00 |
China's Voice in ESC: Exploring the Risk of Thrombosis and Bleeding in Patients with COVID-19 |
Yutao Guo | The Sixth Medical Center of Chinese PLA General Hospital |
12:00-12:30 | 12:00-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Anticoagulant Selection in Patients with Atrial Fibrillation and Coronary Artery Disease |
Lan Huang | Xinqiao Hospital, Army Medical University |
14:15-14:22 | 14:15-14:22 |
Discussion |
||
14:22-14:37 | 14:22-14:37 |
Antiarrhythmic Drug Selection in Patients with Atrial Fibrillation and Coronary Artery Disease |
Peng Qu | The Second Affiliated Hospital of Dalian Medical University |
14:37-14:44 | 14:37-14:44 |
Discussion |
||
14:44-14:59 | 14:44-14:59 |
Individualized Antiplatelet Therapy in Patients with Coronary Artery Disease Treated with Oral Anticoagulants |
Jun Jin | Xinqiao Hospital, Army Medical University |
14:59-15:06 | 14:59-15:06 |
Discussion |
||
15:06-15:21 | 15:06-15:21 |
Selection of Antiplatelet Drugs in Patients with Atrial Fibrillation and Coronary Artery Disease |
Yutang Wang | The Second Medical Center of Chinese PLA General Hospital |
15:21-15:30 | 15:21-15:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Debate: LAA Closure is Recommended for Alternative to Anticoagulation in Patients with Atrial Fibrillation after PCI: Pros |
Zulu Wang | General Hospital of Northern Theater Command |
16:15-16:22 | 16:15-16:22 |
Discussion |
||
16:22-16:37 | 16:22-16:37 |
Debate: Dual Antithrombotic Therapy is the Standard Treatment in AF Patients Undergoing PCI: Pros |
Lijun Guo | Peking University Third Hospital |
16:37-16:44 | 16:37-16:44 |
Discussion |
||
16:44-16:59 | 16:44-16:59 |
Debate: Dual Antithrombotic Therapy is the Standard Treatment in AF Patients Undergoing PCI: Cons |
Yingqing Feng | Guangdong Provincial People's Hospital |
16:59-17:08 | 16:59-17:08 |
Disscussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:05 | 19:00-19:05 |
Opening
Guosheng Fu
Sir Run Run Shaw Hospital /
Genshan Ma
Zhongda Hospital, Southeast University /
Shaobin Jia
General Hospital of Ningxia Medical University
|
||
19:05-19:25 | 19:05-19:25 |
Key Points of the Chinese Expert Consensus on Antithrombotic Management in Patients with Coronary Artery Disease and Atrial Fibrillation |
Shaowen Liu | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
19:25-19:45 | 19:25-19:45 |
Further Insights into the Chinese Expert Consensus on Antithrombotic Management in Patients with Coronary Artery Disease and Atrial Fibrillation |
Shaobin Jia | General Hospital of Ningxia Medical University |
19:45-20:05 | 19:45-20:05 |
Exploration of Anticoagulation for Coronary Thrombosis: A Evidence-Based Analysis |
Jun Zhu | Fuwai Hospital, Chinese Academy of Medical Sciences |
20:05-20:25 | 20:05-20:25 |
Exploration of DPI for Coronary Thrombosis: A Mechanism Analysis |
Yuyang Liu | Beijing Anzhen Hospital, Capital Medical University |
20:25-20:45 | 20:25-20:45 |
Antithrombotic Strategy for Chronic Coronary Syndrome Patients with Peripheral Artery Disease |
Yanmin Yang | Fuwai Hospital of the Chinese Academy of Medical Science |
20:45-21:00 | 20:45-21:00 |
Discussion |